etiracetam (levetiracetam)

07/01/2008 - "Levetiracetam was effective in both partial and primary generalized seizures, but had most effect in partial seizures. "
06/15/2007 - "Treatment with levetiracetam produced a striking remission of seizures. "
10/01/2004 - "Most patients (68%) reported some improvement in seizure frequency on levetiracetam including 16% who became seizure free. "
06/01/2002 - "Levetiracetam, as add-on therapy, was effective in reducing seizure frequency in a variety of seizure types but was most effective for partial-onset seizures. "
04/01/2011 - "Levetiracetam was associated with a greater than 50% seizure reduction in 35% (8 of 23), including seizure termination in 7. Further study is warranted to determine optimal levetiracetam dosing in neonates and to compare efficacy with other antiseizure medications."

08/01/2010 - "Levetiracetam was well tolerated at the doses studied, and appears most effective in single seizure events."
05/01/2008 - "Levetiracetam treatment was safe and effective in this group of very young patients with various types of epilepsy."
01/01/2011 - "The results of the study revealed the high efficacy of levetiracetam as an add-on treatment of pharmacoresistant epilepsy in children. "
08/01/2005 - "Fast and sustained efficacy of levetiracetam during titration and the first 3 months of treatment in refractory epilepsy."
02/01/2003 - "Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy."

08/01/2014 - "Intravenous levetiracetam (LEV) has been shown to be effective and safe in treating adults with refractory status epilepticus (SE). "
03/01/2014 - "Levetiracetam is effective in individuals with electrical status epilepticus during sleep with tolerable side effects."
01/01/2013 - "The relatively recent development of levetiracetam shows promise for effective control of acute status epilepticus in adults, but current objective data of its use as a first-line agent for control of status is quite limited. "
09/01/2009 - "IV levetiracetam was effective in stopping status epilepticus in both infants. "
01/15/2015 - "To investigate the antiepileptic and protective effects of intravenous levetiracetam (iv LEV) in the rhesus monkey model of acute status epilepticus (SE). "

12/01/2000 - "Levetiracetam (LEV) is an interesting novel antiepileptic drug with proven efficacy in both animal models and patients with partial epilepsy. "
01/01/2010 - "The drug withdrawals due to side effects was 5,6% in group 1 and 8,2% in group 2. The results of the study suggest high efficacy of levetiracetam in treatment of partial epilepsy."
03/01/2006 - "This open-label non-controlled study suggests an early efficacy of levetiracetam as add-on therapy in patients with refractory partial epilepsy: these results appear to confirm previous indications of a rapid onset of action and seem to suggest first evaluation of the patient at the dose of 500 mg/day before increasing to the considered minimum standard dose of 1000 mg/day, as some patients could respond to the starting dose."
12/01/2002 - "Levetiracetam may be more effective for late-onset partial epilepsy."
07/01/2008 - "Levetiracetam (LEV) is a new antiepileptic drug that is clinically effective in generalized and partial epilepsy syndromes as sole or add-on medication. "

05/01/2012 - "The administration of levetiracetam alleviated positive myoclonus and suppressed atonic falls, resulting in a remarkable improvement in the patient's quality of daily life. "
03/01/2002 - "Add-on therapy with levetiracetam significantly improved the patient's clinical condition, suppressed cortical myoclonus-associated spikes, and enabled further neurorehabilitation."
06/01/2004 - "Disabling myoclonus is the main symptom in long-standing Unverricht-Lundborg disease (ULD), and levetiracetam (LEV) appears to be an effective anticonvulsant with promising short-term antimyoclonic properties. "
05/01/2003 - "Case reports provide additional information regarding the potential efficacy of levetiracetam in postanoxic, post-encephalitic and progressive myoclonus. "
04/01/2003 - "Levetiracetam is a new antiepileptic drug with a broad-spectrum activity that includes efficacy against positive myoclonus. "